MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
SymbolNYSE:MRT
CUSIPN/A
Phone615-627-4710
Debt
Debt-to-Equity RatioN/A
Current Ratio9.27
Quick Ratio9.27
Price-To-Earnings
Trailing P/E Ratio8.53
Forward P/E Ratio9.25
P/E GrowthN/A
Sales & Book Value
Annual Sales$61.10 million
Price / Sales5.21
Cash Flow$1.2379 per share
Price / Cash8.07
Book Value$11.23 per share
Price / Book0.89
Profitability
EPS (Most Recent Fiscal Year)$1.14
Net Income$20.42 million
Net Margins30.84%
Return on Equity5.73%
Return on Assets3.44%
Miscellaneous
Employees12
Outstanding Shares31,860,000
Market Cap$307.79 million
MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions
What is MedEquities Realty Trust's stock symbol?
MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."
How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?
MedEquities Realty Trust announced a quarterly dividend on Thursday, August 2nd. Investors of record on Wednesday, August 15th will be given a dividend of $0.21 per share on Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a yield of 8.41%. The ex-dividend date is Tuesday, August 14th. View MedEquities Realty Trust's Dividend History.
How were MedEquities Realty Trust's earnings last quarter?
MedEquities Realty Trust Inc (NYSE:MRT) issued its quarterly earnings results on Wednesday, August, 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.30 by $0.20. The financial services provider had revenue of $17.56 million for the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. View MedEquities Realty Trust's Earnings History.
When is MedEquities Realty Trust's next earnings date?
What price target have analysts set for MRT?
8 brokers have issued 12 month price objectives for MedEquities Realty Trust's shares. Their forecasts range from $9.00 to $14.00. On average, they anticipate MedEquities Realty Trust's share price to reach $11.8750 in the next year. This suggests a possible upside of 18.9% from the stock's current price. View Analyst Price Targets for MedEquities Realty Trust.
What is the consensus analysts' recommendation for MedEquities Realty Trust?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust.
What are Wall Street analysts saying about MedEquities Realty Trust stock?
Here are some recent quotes from research analysts about MedEquities Realty Trust stock:
- 1. According to Zacks Investment Research, "MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. " (9/15/2018)
- 2. Cantor Fitzgerald analysts commented, "MRT reported in-line 4Q17 results and issued 2018 guidance that includes fewer acquisitions than we modeled, and we believe could be conservative. Closings have been slower industry-wide, but the backlog of announced deals is good for 2018." (2/21/2018)
Who are some of MedEquities Realty Trust's key competitors?
Some companies that are related to MedEquities Realty Trust include PennyMac Mortgage Investment Trust (PMT), Saul Centers (BFS), CorePoint Lodging (CPLG), TIER REIT (TIER), Easterly Government Properties (DEA), Hannon Armstrong Sustnbl Infrstr Cap (HASI), CYS INVESTMENTS/SH SH (CYS), Ramco-Gershenson Properties Trust (RPT), KKR Real Estate Finance Trust (KREF), Universal Health Realty Income Trust (UHT), ARMOUR Residential REIT (ARR), CYRELA BRAZIL R/S (CYRBY), Chatham Lodging Trust (CLDT), Interrent Real Estate Investment Trust (IIPZF) and InfraREIT (HIFR).
Who are MedEquities Realty Trust's key executives?
MedEquities Realty Trust's management team includes the folowing people:
- Mr. John W. McRoberts, Chairman & CEO (Age 65)
- Mr. William C. Harlan, Pres, COO & Director (Age 66)
- Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 48)
- Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 43)
- Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC
When did MedEquities Realty Trust IPO?
(MRT) raised $259 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 19,900,000 shares at $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.
Has MedEquities Realty Trust been receiving favorable news coverage?
Press coverage about MRT stock has been trending somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MedEquities Realty Trust earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the financial services provider an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for MedEquities Realty Trust.
Who are MedEquities Realty Trust's major shareholders?
MedEquities Realty Trust's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlueMountain Capital Management LLC (6.89%), American Century Companies Inc. (6.81%), BlackRock Inc. (4.70%), Aristotle Capital Boston LLC (2.88%), Renaissance Technologies LLC (2.64%) and Eagle Boston Investment Management Inc. (2.45%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, David L Travis, Jeffery C Walraven, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust.
Which institutional investors are selling MedEquities Realty Trust stock?
MRT stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, BlueMountain Capital Management LLC, Aristotle Capital Boston LLC, GSA Capital Partners LLP, Moody Lynn & Lieberson LLC, Victory Capital Management Inc. and Raymond James & Associates. View Insider Buying and Selling for MedEquities Realty Trust.
Which institutional investors are buying MedEquities Realty Trust stock?
MRT stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Sterling Capital Management LLC, BlackRock Inc., American Century Companies Inc., Eagle Boston Investment Management Inc., Sei Investments Co., Putnam Investments LLC and Dynamic Technology Lab Private Ltd. Company insiders that have bought MedEquities Realty Trust stock in the last two years include David L Travis, Jeffery C Walraven, John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust.
How do I buy shares of MedEquities Realty Trust?
Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MedEquities Realty Trust's stock price today?
One share of MRT stock can currently be purchased for approximately $9.99.
How big of a company is MedEquities Realty Trust?
MedEquities Realty Trust has a market capitalization of $307.79 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe.
How can I contact MedEquities Realty Trust?
MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]
MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
